Osteoporosis drugs on every 2026 Texas Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Texas cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
12 plans, cheapest premium first. Scroll sideways for all of them →
| Drug | Wellcare Classic$0.00/moS4802-013 | Wellcare Value Script$0.00/moS4802-155 | Humana Value Rx Plan$22.90/moS5884-201 | Humana Basic Rx Plan$41.70/moS5884-143 | HealthSpring Extra Rx$70.00/moS5617-372 | AARP Medicare Rx Saver from UHC$89.20/moS5921-367 | SilverScript Choice$94.80/moS5601-044 | Blue Cross MedicareRx Basic$104.70/moS5715-014 | HealthSpring Assurance Rx$111.40/moS5617-108 | AARP Medicare Rx Preferred from UHC$114.80/moS5921-403 | Humana Premier Rx Plan$118.20/moS5884-168 | Blue Cross MedicareRx Value$167.40/moS5715-005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| alendronategeneric Fosamax | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 2$1.00QL 30/30d | Tier 1$0.00 | Tier 2$7.00QL 30/30d | Tier 1$0.00 | Tier 1$0.00QL 120/30d | Tier 1$0.00QL 30/30d | Tier 1$5.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 120/30d |
| risedronategeneric Actonel | Not covered | Tier 2$3.00QL 1/30d | Not covered | Not covered | Not covered | Not covered | Tier 433%QL 1/28d | Not covered | Not covered | Not covered | Not covered | Tier 318%QL 1/28d |
| ibandronategeneric Boniva | Tier 325%QL 1/30d | Tier 2$3.00QL 1/30d | Tier 320%QL 1/28d | Tier 325%QL 1/28d | Tier 317%QL 1/28d | Tier 318%QL 1/28d | Tier 433%QL 1/30d | Tier 2$5.00QL 1/28d | Tier 321%QL 1/28d | Tier 318%QL 1/28d | Tier 3$45.00QL 1/28d | Tier 2$1.00QL 1/28d |
| Proliadenosumab | Not covered | Not covered | Tier 434%QL 1/180d | Tier 434%QL 1/180d | Tier 430%QL 1/180d | Not covered | Not covered | Not covered | Tier 431%QL 1/180d | Not covered | Tier 450%QL 1/180d | Not covered |
| denosumab biosimilarsJubbonti, Ospomyv and others | Tier 429%QL 1/180d | Tier 440%QL 1/180d | Not covered | Not covered | Not covered | Tier 438%QL 1/180d | Tier 433%QL 1/180d | Tier 4PA42% | Not covered | Tier 435%QL 1/180d | Not covered | Tier 4PA32% |
| Evenityromosozumab | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Forteoteriparatide | Not covered | Not covered | Tier 5PA26%QL 2.24/28d | Tier 5PA25%QL 2.24/28d | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA33%QL 2.24/28d | Not covered |
| teriparatidegeneric Forteo | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Not covered | Not covered | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Tier 5PA25% | Not covered | Tier 5PA25%QL 2.48/28d | Tier 5PA31%QL 2.48/28d | Not covered | Tier 5PA25% |
| Tymlosabaloparatide | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA25% | Tier 5PA25% | Not covered | Tier 5PA31%QL 1.56/30d | Not covered | Tier 5PA25% |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.